Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis
被引:17
作者:
Higuchi, Chieko
论文数: 0引用数: 0
h-index: 0
机构:
Tokyo Womens Med Univ, Med Ctr E, Div Internal Med, Arakawa Ku, Tokyo, JapanTokyo Womens Med Univ, Med Ctr E, Div Internal Med, Arakawa Ku, Tokyo, Japan
Higuchi, Chieko
[1
]
Nishimura, Hideki
论文数: 0引用数: 0
h-index: 0
机构:
Tokyo Womens Med Univ, Med Ctr E, Div Internal Med, Arakawa Ku, Tokyo, JapanTokyo Womens Med Univ, Med Ctr E, Div Internal Med, Arakawa Ku, Tokyo, Japan
Nishimura, Hideki
[1
]
Sanaka, Tsutomu
论文数: 0引用数: 0
h-index: 0
机构:
Tokyo Womens Med Univ, Med Ctr E, Div Internal Med, Arakawa Ku, Tokyo, JapanTokyo Womens Med Univ, Med Ctr E, Div Internal Med, Arakawa Ku, Tokyo, Japan
Sanaka, Tsutomu
[1
]
机构:
[1] Tokyo Womens Med Univ, Med Ctr E, Div Internal Med, Arakawa Ku, Tokyo, Japan
Conventional peritoneal dialysis fluid (PDF) is a bioincompatible solution because of several components. These unphysiological compositions might contribute to the development of peritoneal fibrosis. In the present overview we summarize the influence of each composition of PDF (acidic pH, high concentration of glucose and glucose degradation products; advanced glycation end-products and lactate) on the peritoneal fibrotic changes in long peritoneal dialysis (PD) patients. We also summarized the report of new approaches to the prevention of peritoneal fibrosis in Japan.